KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Long-Term Investments (2016 - 2025)

Astrana Health (ASTH) has disclosed Long-Term Investments for 10 consecutive years, with $25.6 million as the latest value for Q4 2025.

  • Quarterly Long-Term Investments fell 34.8% to $25.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.6 million through Dec 2025, down 34.8% year-over-year, with the annual reading at $25.6 million for FY2025, 34.8% down from the prior year.
  • Long-Term Investments hit $25.6 million in Q4 2025 for Astrana Health, up from $18.5 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $45.8 million in Q2 2023 to a low of $18.5 million in Q3 2025.
  • Historically, Long-Term Investments has averaged $37.9 million across 5 years, with a median of $39.1 million in 2022.
  • Biggest five-year swings in Long-Term Investments: surged 65.49% in 2021 and later tumbled 46.69% in 2025.
  • Year by year, Long-Term Investments stood at $41.7 million in 2021, then dropped by 3.39% to $40.3 million in 2022, then plummeted by 36.04% to $25.8 million in 2023, then surged by 52.55% to $39.3 million in 2024, then crashed by 34.8% to $25.6 million in 2025.
  • Business Quant data shows Long-Term Investments for ASTH at $25.6 million in Q4 2025, $18.5 million in Q3 2025, and $38.5 million in Q2 2025.